Diagnostic Robotics, founded in 2017, is revolutionizing the healthcare sector with its AI-Driven Care solutions, ensuring processes remain Automated, Scalable, and Seamless. The company’s core offerings include Automated Outreach, prioritizing high-risk cases through advanced AI tools, while integrating smoothly with existing EHR and care management systems.
Headquartered in the United States, this innovative firm actively engages patients and eases healthcare workflows without requiring additional staff. Relevant to investors, the company received a notable $45.00M Series B investment on 25 July 2022. Esteemed investors like Alpha Capital, Accelmed Partners, StageOne Ventures, and Mayo Clinic underscore the company's ability to captivate major stakeholders while pursuing its mission of Improving healthcare worldwide.